← All trials
NCT04689958
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 3, 2020
- Primary completion
- Nov 30, 2021
- Completion date
- Nov 30, 2021
- First posted
- Dec 30, 2020
- Last posted
- Dec 30, 2020
- Enrollment
- 60
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Duta Wacana Christian UniversityLead sponsor
- Duta Wacana Christian UniversityReponsible party - principal investigator
- Duta Wacana Christian UniversityOverall official - principal investigator
- PT SOHO Global Health TbkCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.